BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 17547995)

  • 1. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esthesioneuroblastoma: the University of Iowa experience 1978-1998.
    Simon JH; Zhen W; McCulloch TM; Hoffman HT; Paulino AC; Mayr NA; Buatti JM
    Laryngoscope; 2001 Mar; 111(3):488-93. PubMed ID: 11224781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
    Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
    Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
    Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
    Diaz EM; Johnigan RH; Pero C; El-Naggar AK; Roberts DB; Barker JL; DeMonte F
    Head Neck; 2005 Feb; 27(2):138-49. PubMed ID: 15654688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esthesioneuroblastoma: The Princess Margaret Hospital experience.
    Bachar G; Goldstein DP; Shah M; Tandon A; Ringash J; Pond G; Gullane PJ; Perez-Ordonez B; Gilbert RW; Brown DH; Gentili F; O'Sullivan B; Irish JC
    Head Neck; 2008 Dec; 30(12):1607-14. PubMed ID: 18798301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
    Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
    Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors and outcome of esthesioneuroblastoma].
    Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
    Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
    Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure and outcome in esthesioneuroblastoma.
    Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intracranial metastatic esthesioneuroblastoma.
    Chamberlain MC
    Cancer; 2002 Jul; 95(2):243-8. PubMed ID: 12124822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
    El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.